Wells Fargo’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.97K | Sell |
967
-21,402
| -96% | -$43.6K | ﹤0.01% | 5757 |
|
2025
Q1 | $36.5K | Buy |
22,369
+5,681
| +34% | +$9.26K | ﹤0.01% | 5044 |
|
2024
Q4 | $30.5K | Buy |
16,688
+3,238
| +24% | +$5.93K | ﹤0.01% | 5144 |
|
2024
Q3 | $77.7K | Buy |
13,450
+333
| +3% | +$1.93K | ﹤0.01% | 4759 |
|
2024
Q2 | $106K | Buy |
13,117
+11,618
| +775% | +$93.9K | ﹤0.01% | 4548 |
|
2024
Q1 | $20.8K | Sell |
1,499
-322
| -18% | -$4.47K | ﹤0.01% | 5182 |
|
2023
Q4 | $11.1K | Buy |
1,821
+261
| +17% | +$1.6K | ﹤0.01% | 5368 |
|
2023
Q3 | $7.28K | Sell |
1,560
-165
| -10% | -$770 | ﹤0.01% | 5501 |
|
2023
Q2 | $9.24K | Sell |
1,725
-35,217
| -95% | -$189K | ﹤0.01% | 5619 |
|
2023
Q1 | $364K | Buy |
36,942
+35,307
| +2,159% | +$347K | ﹤0.01% | 3805 |
|
2022
Q4 | $30.6K | Sell |
1,635
-1,269
| -44% | -$23.8K | ﹤0.01% | 4770 |
|
2022
Q3 | $60K | Sell |
2,904
-497
| -15% | -$10.3K | ﹤0.01% | 4564 |
|
2022
Q2 | $71K | Sell |
3,401
-4,816
| -59% | -$101K | ﹤0.01% | 4583 |
|
2022
Q1 | $354K | Sell |
8,217
-11,947
| -59% | -$515K | ﹤0.01% | 4363 |
|
2021
Q4 | $1.21M | Buy |
20,164
+3,859
| +24% | +$231K | ﹤0.01% | 3726 |
|
2021
Q3 | $1.4M | Buy |
16,305
+5,731
| +54% | +$493K | ﹤0.01% | 3750 |
|
2021
Q2 | $1.18M | Buy |
10,574
+581
| +6% | +$64.6K | ﹤0.01% | 3883 |
|
2021
Q1 | $1.11M | Sell |
9,993
-24,764
| -71% | -$2.76M | ﹤0.01% | 3914 |
|
2020
Q4 | $3.69M | Buy |
34,757
+2,366
| +7% | +$251K | ﹤0.01% | 2979 |
|
2020
Q3 | $4.51M | Sell |
32,391
-2,016
| -6% | -$281K | ﹤0.01% | 2582 |
|
2020
Q2 | $11.1M | Buy |
34,407
+27,583
| +404% | +$8.92M | ﹤0.01% | 1759 |
|
2020
Q1 | $609K | Buy |
6,824
+65
| +1% | +$5.8K | ﹤0.01% | 3784 |
|
2019
Q4 | $268K | Sell |
6,759
-9,551
| -59% | -$379K | ﹤0.01% | 4651 |
|
2019
Q3 | $401K | Buy |
16,310
+552
| +4% | +$13.6K | ﹤0.01% | 4399 |
|
2019
Q2 | $556K | Sell |
15,758
-6,092
| -28% | -$215K | ﹤0.01% | 4196 |
|
2019
Q1 | $978K | Buy |
21,850
+7,892
| +57% | +$353K | ﹤0.01% | 3857 |
|
2018
Q4 | $670K | Buy |
13,958
+7,465
| +115% | +$358K | ﹤0.01% | 4040 |
|
2018
Q3 | $434K | Buy |
6,493
+199
| +3% | +$13.3K | ﹤0.01% | 4418 |
|
2018
Q2 | $296K | Sell |
6,294
-8,862
| -58% | -$417K | ﹤0.01% | 4668 |
|
2018
Q1 | $857K | Buy |
15,156
+239
| +2% | +$13.5K | ﹤0.01% | 3954 |
|
2017
Q4 | $739K | Buy |
14,917
+6,277
| +73% | +$311K | ﹤0.01% | 4035 |
|
2017
Q3 | $657K | Buy |
8,640
+1,195
| +16% | +$90.9K | ﹤0.01% | 4062 |
|
2017
Q2 | $701K | Sell |
7,445
-2,935
| -28% | -$276K | ﹤0.01% | 3912 |
|
2017
Q1 | $825K | Buy |
10,380
+2,324
| +29% | +$185K | ﹤0.01% | 3814 |
|
2016
Q4 | $671K | Buy |
8,056
+1,213
| +18% | +$101K | ﹤0.01% | 3906 |
|
2016
Q3 | $765K | Buy |
6,843
+16
| +0.2% | +$1.79K | ﹤0.01% | 3598 |
|
2016
Q2 | $757K | Buy |
6,827
+208
| +3% | +$23.1K | ﹤0.01% | 3598 |
|
2016
Q1 | $693K | Buy |
6,619
+573
| +9% | +$60K | ﹤0.01% | 3583 |
|
2015
Q4 | $487K | Buy |
6,046
+573
| +10% | +$46.2K | ﹤0.01% | 3833 |
|
2015
Q3 | $379K | Sell |
5,473
-24
| -0.4% | -$1.66K | ﹤0.01% | 3990 |
|
2015
Q2 | $538K | Buy |
5,497
+1,450
| +36% | +$142K | ﹤0.01% | 3957 |
|
2015
Q1 | $396K | Buy |
4,047
+3,814
| +1,637% | +$373K | ﹤0.01% | 3988 |
|
2014
Q4 | $26K | Sell |
233
-39
| -14% | -$4.35K | ﹤0.01% | 5048 |
|
2014
Q3 | $32K | Sell |
272
-427
| -61% | -$50.2K | ﹤0.01% | 4962 |
|
2014
Q2 | $90K | Buy |
699
+149
| +27% | +$19.2K | ﹤0.01% | 4612 |
|
2014
Q1 | $88K | Buy |
+550
| New | +$88K | ﹤0.01% | 4613 |
|